rs8176345

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000785.4(CYP27B1):​c.942G>A​(p.Leu314Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0278 in 1,614,152 control chromosomes in the GnomAD database, including 720 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 49 hom., cov: 33)
Exomes 𝑓: 0.028 ( 671 hom. )

Consequence

CYP27B1
NM_000785.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.00900

Publications

27 publications found
Variant links:
Genes affected
CYP27B1 (HGNC:2606): (cytochrome P450 family 27 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the inner mitochondrial membrane where it hydroxylates 25-hydroxyvitamin D3 at the 1alpha position. This reaction synthesizes 1alpha,25-dihydroxyvitamin D3, the active form of vitamin D3, which binds to the vitamin D receptor and regulates calcium metabolism. Thus this enzyme regulates the level of biologically active vitamin D and plays an important role in calcium homeostasis. Mutations in this gene can result in vitamin D-dependent rickets type I. [provided by RefSeq, Jul 2008]
CYP27B1 Gene-Disease associations (from GenCC):
  • vitamin D-dependent rickets, type 1A
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • vitamin D-dependent rickets, type 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 12-57764775-C-T is Benign according to our data. Variant chr12-57764775-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 880899.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.009 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0212 (3223/152272) while in subpopulation NFE AF = 0.0321 (2180/68000). AF 95% confidence interval is 0.0309. There are 49 homozygotes in GnomAd4. There are 1465 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 49 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP27B1NM_000785.4 linkc.942G>A p.Leu314Leu synonymous_variant Exon 5 of 9 ENST00000228606.9 NP_000776.1 O15528

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP27B1ENST00000228606.9 linkc.942G>A p.Leu314Leu synonymous_variant Exon 5 of 9 1 NM_000785.4 ENSP00000228606.4 O15528

Frequencies

GnomAD3 genomes
AF:
0.0212
AC:
3225
AN:
152154
Hom.:
49
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00550
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.0210
Gnomad ASJ
AF:
0.0749
Gnomad EAS
AF:
0.000964
Gnomad SAS
AF:
0.00746
Gnomad FIN
AF:
0.00725
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0321
Gnomad OTH
AF:
0.0263
GnomAD2 exomes
AF:
0.0231
AC:
5798
AN:
251472
AF XY:
0.0235
show subpopulations
Gnomad AFR exome
AF:
0.00548
Gnomad AMR exome
AF:
0.0150
Gnomad ASJ exome
AF:
0.0650
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00864
Gnomad NFE exome
AF:
0.0348
Gnomad OTH exome
AF:
0.0271
GnomAD4 exome
AF:
0.0285
AC:
41606
AN:
1461880
Hom.:
671
Cov.:
33
AF XY:
0.0281
AC XY:
20463
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.00469
AC:
157
AN:
33480
American (AMR)
AF:
0.0160
AC:
715
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0707
AC:
1847
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00846
AC:
730
AN:
86258
European-Finnish (FIN)
AF:
0.0102
AC:
543
AN:
53416
Middle Eastern (MID)
AF:
0.0321
AC:
185
AN:
5768
European-Non Finnish (NFE)
AF:
0.0322
AC:
35778
AN:
1112002
Other (OTH)
AF:
0.0273
AC:
1649
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
2583
5165
7748
10330
12913
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1300
2600
3900
5200
6500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0212
AC:
3223
AN:
152272
Hom.:
49
Cov.:
33
AF XY:
0.0197
AC XY:
1465
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00548
AC:
228
AN:
41568
American (AMR)
AF:
0.0210
AC:
321
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0749
AC:
260
AN:
3470
East Asian (EAS)
AF:
0.000966
AC:
5
AN:
5174
South Asian (SAS)
AF:
0.00726
AC:
35
AN:
4822
European-Finnish (FIN)
AF:
0.00725
AC:
77
AN:
10618
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0321
AC:
2180
AN:
68000
Other (OTH)
AF:
0.0260
AC:
55
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
162
323
485
646
808
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0310
Hom.:
381
Bravo
AF:
0.0225
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0378
EpiControl
AF:
0.0388

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 28, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Vitamin D-dependent rickets, type 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
9.7
DANN
Benign
0.91
PhyloP100
-0.0090
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8176345; hg19: chr12-58158558; COSMIC: COSV107995758; COSMIC: COSV107995758; API